by | Aug 23, 2022 | Publications
Int J Infect Dis. 2022 Jul 25:S1201-9712(22)00440-4. doi: 10.1016/j.ijid.2022.07.043. Online ahead of print. ABSTRACT BACKGROUND: . Although only 10% of persons infected with HTLV-1 may develop virus-associated illnesses lifelong, missing the earlier diagnosis of...
by | Aug 23, 2022 | Publications
Viruses. 2022 Jul 26;14(8):1633. doi: 10.3390/v14081633. ABSTRACT In the original publication […]. PMID:35893703 | PMC:PMC9331114 | DOI:10.3390/v14081633
by | Aug 23, 2022 | Publications
Clin Infect Dis. 2022 Jul 29:ciac614. doi: 10.1093/cid/ciac614. Online ahead of print. ABSTRACT BACKGROUND: A link between chronic inflammation and several non-communicable diseases (NCD) has been established. Although chronic infection with the human T-cell leukaemia...
by HTLV | Aug 21, 2022 | Publications
J Neurovirol. 2022 Jul 30. doi: 10.1007/s13365-022-01088-x. Online ahead of print. ABSTRACT Up to 3.8% of human T-lymphotropic virus type-1 (HTLV-1)-infected asymptomatic carriers (AC) eventually develop HTLV-1-associated myelopathy (HAM). HAM occurs in patients with...
by HTLV | Aug 21, 2022 | Publications
Front Immunol. 2022 Jul 22;13:957535. doi: 10.3389/fimmu.2022.957535. eCollection 2022. ABSTRACT The Human T-cell Leukemia virus type 1 (HTLV-1) causes an array of pathologies, the most aggressive of which is adult T-cell leukemia (ATL), a fatal blood malignancy with...
by HTLV | Aug 21, 2022 | Publications
Microbiol Immunol. 2022 Aug 4. doi: 10.1111/1348-0421.13022. Online ahead of print. ABSTRACT Mannose binding lectin-associated serine protease 2 (MASP2) is the effector part of mannose binding lectin (MBL) that activates the complement system in an...
